Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands |
3 Months Ended |
6 Months Ended |
Jun. 30, 2015 |
Jun. 30, 2014 |
Jun. 30, 2015 |
Jun. 30, 2014 |
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
$ (13,934)
|
$ 15,837
|
$ (10,156)
|
$ 3,445
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
38,351
|
36,180
|
78,890
|
70,517
|
| Accretion Expense |
|
|
306
|
0
|
| Other Asset Impairment Charges |
2,316
|
0
|
2,316
|
0
|
| Loss on extinguishment of debt |
0
|
(479)
|
0
|
(30,152)
|
| (Gain) loss on disposition of assets |
138
|
(1,019)
|
(2,303)
|
(890)
|
| Deferred income tax benefit |
|
|
(17,126)
|
8,358
|
| Expenses not requiring cash |
|
|
5,308
|
8,748
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
39,683
|
(1,066)
|
| Accrued income taxes |
|
|
(1,236)
|
(3,987)
|
| Other assets |
|
|
(7,352)
|
(777)
|
| Accounts payable and accrued liabilities |
|
|
14,763
|
5,789
|
| Net cash provided by operating activities |
|
|
103,093
|
103,573
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(54,605)
|
(106,188)
|
| Proceeds from the sale of assets |
|
|
288
|
3,346
|
| Proceeds from insurance settlements |
|
|
2,500
|
0
|
| Net cash (used in) investing activities |
|
|
(62,248)
|
(102,842)
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from debt issuance |
|
|
|
400,000
|
| Repayments of long-term debt |
|
|
|
(430,000)
|
| Paydown on term note |
|
|
(30,000)
|
(430,000)
|
| Payment of debt issuance costs |
|
|
(1,359)
|
(7,425)
|
| Payments of debt extinguishment costs |
|
|
0
|
(26,214)
|
| Excess tax benefit from stock-based compensation |
|
|
(999)
|
665
|
| Intercompany advances, net |
|
|
0
|
0
|
| Net cash (used in) financing activities |
|
|
(32,358)
|
(62,974)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
8,487
|
(62,243)
|
| Cash and cash equivalents, beginning of year |
|
|
108,456
|
148,689
|
| Cash and cash equivalents, end of period |
116,943
|
86,446
|
116,943
|
86,446
|
| Parent [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(14,029)
|
15,681
|
(10,807)
|
3,132
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
0
|
0
|
0
|
0
|
| Accretion Expense |
|
|
0
|
|
| Other Asset Impairment Charges |
0
|
|
0
|
|
| Loss on extinguishment of debt |
|
|
|
(30,152)
|
| (Gain) loss on disposition of assets |
0
|
0
|
0
|
80
|
| Deferred income tax benefit |
|
|
22,414
|
19,621
|
| Expenses not requiring cash |
|
|
4,039
|
7,939
|
| Equity in net earnings of subsidiaries |
8,392
|
(20,659)
|
(597)
|
(31,149)
|
| Accounts and notes receivable |
|
|
0
|
0
|
| Accrued income taxes |
|
|
2,146
|
(5,231)
|
| Other assets |
|
|
(77,427)
|
37,589
|
| Accounts payable and accrued liabilities |
|
|
29
|
(19,629)
|
| Net cash provided by operating activities |
|
|
(105,031)
|
3,262
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
0
|
0
|
| Proceeds from the sale of assets |
|
|
0
|
0
|
| Proceeds from insurance settlements |
|
|
0
|
|
| Net cash (used in) investing activities |
|
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from debt issuance |
|
|
|
400,000
|
| Repayments of long-term debt |
|
|
|
(430,000)
|
| Paydown on term note |
|
|
(30,000)
|
|
| Payment of debt issuance costs |
|
|
(1,359)
|
(7,425)
|
| Payments of debt extinguishment costs |
|
|
|
26,214
|
| Excess tax benefit from stock-based compensation |
|
|
(999)
|
665
|
| Intercompany advances, net |
|
|
142,814
|
(2,619)
|
| Net cash (used in) financing activities |
|
|
110,456
|
(65,593)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
5,425
|
(62,331)
|
| Cash and cash equivalents, beginning of year |
|
|
36,728
|
88,697
|
| Cash and cash equivalents, end of period |
42,153
|
26,366
|
42,153
|
26,366
|
| Guarantor [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(7,187)
|
22,148
|
(4,868)
|
34,191
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
23,958
|
21,008
|
47,268
|
41,175
|
| Accretion Expense |
|
|
0
|
|
| Other Asset Impairment Charges |
0
|
|
0
|
|
| Loss on extinguishment of debt |
|
|
|
0
|
| (Gain) loss on disposition of assets |
6
|
(512)
|
(45)
|
(432)
|
| Deferred income tax benefit |
|
|
(6,574)
|
(8,917)
|
| Expenses not requiring cash |
|
|
441
|
(997)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
27,778
|
(6,132)
|
| Accrued income taxes |
|
|
229
|
9,481
|
| Other assets |
|
|
59,964
|
(51,431)
|
| Accounts payable and accrued liabilities |
|
|
14,890
|
20,886
|
| Net cash provided by operating activities |
|
|
152,231
|
55,658
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(37,794)
|
(79,374)
|
| Proceeds from the sale of assets |
|
|
82
|
1,008
|
| Proceeds from insurance settlements |
|
|
0
|
|
| Net cash (used in) investing activities |
|
|
(48,143)
|
(78,366)
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from debt issuance |
|
|
|
0
|
| Repayments of long-term debt |
|
|
|
0
|
| Paydown on term note |
|
|
0
|
|
| Payment of debt issuance costs |
|
|
0
|
0
|
| Payments of debt extinguishment costs |
|
|
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
| Intercompany advances, net |
|
|
(97,138)
|
21,836
|
| Net cash (used in) financing activities |
|
|
(97,138)
|
21,836
|
| Net increase (decrease) in cash and cash equivalents |
|
|
6,950
|
(872)
|
| Cash and cash equivalents, beginning of year |
|
|
13,546
|
8,310
|
| Cash and cash equivalents, end of period |
20,496
|
7,438
|
20,496
|
7,438
|
| Non-Guarantor [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(1,110)
|
(1,333)
|
6,116
|
(2,729)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
14,393
|
15,172
|
31,622
|
29,342
|
| Accretion Expense |
|
|
306
|
|
| Other Asset Impairment Charges |
2,316
|
|
2,316
|
|
| Loss on extinguishment of debt |
|
|
|
0
|
| (Gain) loss on disposition of assets |
132
|
(507)
|
(2,258)
|
(538)
|
| Deferred income tax benefit |
|
|
1,286
|
(2,346)
|
| Expenses not requiring cash |
|
|
828
|
1,806
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
11,905
|
5,066
|
| Accrued income taxes |
|
|
(3,611)
|
(8,237)
|
| Other assets |
|
|
10,111
|
13,065
|
| Accounts payable and accrued liabilities |
|
|
(156)
|
4,532
|
| Net cash provided by operating activities |
|
|
55,893
|
44,653
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(16,811)
|
(26,814)
|
| Proceeds from the sale of assets |
|
|
206
|
2,338
|
| Proceeds from insurance settlements |
|
|
2,500
|
|
| Net cash (used in) investing activities |
|
|
(14,105)
|
(24,476)
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from debt issuance |
|
|
|
0
|
| Repayments of long-term debt |
|
|
|
0
|
| Paydown on term note |
|
|
0
|
|
| Payment of debt issuance costs |
|
|
0
|
0
|
| Payments of debt extinguishment costs |
|
|
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
| Intercompany advances, net |
|
|
(45,676)
|
(19,217)
|
| Net cash (used in) financing activities |
|
|
(45,676)
|
(19,217)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
(3,888)
|
960
|
| Cash and cash equivalents, beginning of year |
|
|
58,182
|
51,682
|
| Cash and cash equivalents, end of period |
54,294
|
52,642
|
54,294
|
52,642
|
| Eliminations [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
8,392
|
(20,659)
|
(597)
|
(31,149)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
0
|
0
|
0
|
0
|
| Accretion Expense |
|
|
0
|
|
| Other Asset Impairment Charges |
0
|
|
0
|
|
| Loss on extinguishment of debt |
|
|
|
0
|
| (Gain) loss on disposition of assets |
0
|
0
|
0
|
0
|
| Deferred income tax benefit |
|
|
0
|
0
|
| Expenses not requiring cash |
|
|
0
|
0
|
| Equity in net earnings of subsidiaries |
(8,392)
|
20,659
|
597
|
31,149
|
| Accounts and notes receivable |
|
|
0
|
0
|
| Accrued income taxes |
|
|
0
|
0
|
| Other assets |
|
|
0
|
0
|
| Accounts payable and accrued liabilities |
|
|
0
|
0
|
| Net cash provided by operating activities |
|
|
0
|
0
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
0
|
0
|
| Proceeds from the sale of assets |
|
|
0
|
0
|
| Proceeds from insurance settlements |
|
|
0
|
|
| Net cash (used in) investing activities |
|
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from debt issuance |
|
|
|
0
|
| Repayments of long-term debt |
|
|
|
0
|
| Paydown on term note |
|
|
0
|
|
| Payment of debt issuance costs |
|
|
0
|
0
|
| Payments of debt extinguishment costs |
|
|
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
| Intercompany advances, net |
|
|
0
|
0
|
| Net cash (used in) financing activities |
|
|
0
|
0
|
| Net increase (decrease) in cash and cash equivalents |
|
|
0
|
0
|
| Cash and cash equivalents, beginning of year |
|
|
0
|
0
|
| Cash and cash equivalents, end of period |
$ 0
|
$ 0
|
$ 0
|
$ 0
|